Results 281 to 290 of about 11,442,264 (328)

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Predictors of healthcare seeking for tuberculosis symptoms in the private healthcare facilities: findings from a cross-sectional population-based survey in Tamil Nadu. [PDF]

BMJ Open
Giridharan P, Arangba S, Nagarajan K, Frederick A, Thiruvengadam K, Selvaraju S.   +5 more
europepmc   +1 more source

The Restricted Access of Information Structure to Syntax - A Minority Report

, 2007
Gisbert Fanselow
openalex   +1 more source

Advice From Adolescents With Cancer, Their Caregivers, and Clinicians on Utilizing and Improving Patient Portals in Adolescent Oncology Care. [PDF]

Pediatr Blood Cancer
McGlynn MC, Mirpuri KK, Bereitschaft C, Blazin LJ, Ilowite M, Mack JW, DuBois JM, Sisk BA.   +7 more
europepmc   +1 more source

Constraints of Access to Agricultural Information in Africa: A Systematic Review. [PDF]

ScientificWorldJournal
Abate MA.
europepmc   +1 more source

Global Access to Science Information: The Changing Dynamics of Access and Practices in India

, 2007
Manik Mandal, Keshab Panda
openalex   +1 more source